Inactive Instrument

Aceto Corporation

Robert A. Wiesen Omits to Stand for Re-Election to the Board of Aceto Corporation

August 12, 2013 at 02:52 pm EDT

Aceto Corporation announced that on August 7, 2013, Robert A. Wiesen, a member of the Board of Directors provided notice to the company of his decision to not stand for re-election to the Board at the company's next Annual Meeting of Shareholders, which is expected to be held in December 2013.

Latest news about Aceto Corporation

Actylis Announces Appointment of Scott Thomson as Chief Executive Officer	Jun. 17	CI
Actylis and Novo Nordisk Pharmatech Announce a Strategic Partnership for the Distribution of Benzalkonium Chloride in Targeted European Countries	Mar. 25	CI
Actylis Launches A New Cgmp Wfi Generation, Storage, and Distribution System with Additional Iso Class 7 Manufacturing Space	23-09-21	CI
Actylis Opens a 30,000Ft² cGMP Facility to Bolster its Innovative Api Manufacturing Capabilities	23-02-27	CI
Aceto Corporation acquired Talus Mineral Company and Biotron Laboratories, Inc.	22-03-01	CI
Aceto Corporation acquired A & C Bio Buffer Limited.	21-10-11	CI
Aceto Corporation acquired Cascade Chemistry.	21-06-01	CI
Aceto Corporation acquired an unknown majority stake in Finar Ltd.	21-05-16	CI
Aceto Strengthens Self-Manufacturing and Vaccine and Biopharmaceutical Offering with Acquisition of A&C	21-04-15	CI
Aceto Corporation acquired A&C.	21-04-14	CI
Aceto to Expand Bioreagent Offering to Support Growing Customer Demand in Biopharma and Cell Culture Manufacturing	21-03-15	CI
Aceto Corporation acquired IsleChem, LLC.	20-12-20	CI
Aceto Corporation's Equity Buyback announced on December 11, 2009, has expired.	20-05-30	CI
Aceto Corporation completed the acquisition of Syntor Fine Chemicals Limited.	20-04-16	CI
Aceto Corporation agreed to acquire Syntor Fine Chemicals Limited.	20-04-05	CI
Aceto Corporation Went Out of Business	19-10-01	CI
Second Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-09-20	CI
Second Modified Joint Liquidation Plan and Disclosure Statement Approved for Aceto Corporation	19-09-18	CI
Motion for Asset Sale Approved for Aceto Corporation	19-09-04	CI
Motion for Asset Sale Filed by Aceto Corporation	19-08-12	CI
Disclosure Statement Approved on Interim Basis for Aceto Corporation	19-07-26	CI
Aceto Announces Management Changes	19-06-20	CI
Aceto Corporation Announces Executive Changes	19-06-18	CI
First Motion for Exclusivity Period Extension Approved For Aceto Corporation	19-06-18	CI
Joint Liquidation Plan and Disclosure Statement Filed by Aceto Corporation	19-06-17	CI

Chart Aceto Corporation

Duration

Period

More charts

Company Profile

Tri Harbor Holdings Corp., also known as Aceto, is a United States-based virtual manufacturer engaged in supplying specialty materials. The Company is primarily engaged in supplying its materials to life sciences and advanced technology end markets. The Company operates its business operations in nine countries, and distributes over 1,100 chemical compounds used principally by the pharmaceutical, nutraceutical, agricultural, and specialty chemical industries.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+62.66%	854B
NOVO NORDISK A/S	+40.42%	636B
JOHNSON & JOHNSON	-4.37%	361B
MERCK & CO., INC.	+17.16%	324B
ABBVIE INC.	+9.87%	301B
ASTRAZENECA PLC	+15.66%	247B
ROCHE HOLDING AG	+4.21%	230B
NOVARTIS AG	+17.90%	228B
AMGEN INC.	+14.86%	177B

Other Pharmaceuticals